MicroRNA-372-3p impairs fatty acid metabolism in hepatocellular carcinoma cells by targeting <i>CPT1A</i> and <i>ACSL4</i>

miR‑372‑3p functions as a tumor suppressor in HCC by directly downregulating <i>CPT1A</i> and <i>ACSL4</i>, thereby inhibiting FAO and disrupting lipid metabolism. Targeting this miRNA and FAO axis may offer a novel therapeutic strategy for HCC.

Authors

Institutions

Publication Details

Journal
Bioimpacts
Published
2025-08-20
DOI
https://doi.org/10.34172/bi.31075
Citations
2
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
1.87
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MicroRNA-372-3p impairs fatty acid metabolism in hepatocellular carcinoma cells by targeting CPT1A and ACSL4

Chinnatam Phetkong, Chaiyaboot Ariyachet, Pisit Tangkijvanich, Pannathon Thamjamrassri et al.
2 citations
Bioimpacts
Cancer, Lipids, and Metabolism
1.87
article

MicroRNA-372-3p impairs fatty acid metabolism in hepatocellular carcinoma cells by targeting CPT1A and ACSL4

Chinnatam Phetkong, Chaiyaboot Ariyachet, Pisit Tangkijvanich, Pannathon Thamjamrassri, Thammachanok Boonto
article en
2 citations

Abstract

miR‑372‑3p functions as a tumor suppressor in HCC by directly downregulating <i>CPT1A</i> and <i>ACSL4</i>, thereby inhibiting FAO and disrupting lipid metabolism. Targeting this miRNA and FAO axis may offer a novel therapeutic strategy for HCC.

BioimpactsVol. 15
Chulalongkorn University (TH)
Openalex Percentile: Top 12%
Cancer, Lipids, and Metabolism
1.87
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.